Outcomes between DVT-only and AF cohorts
After propensity matching, there was no substantial difference in the
baseline characteristics between the DVT-only and AF cohorts
(Supplemental table 1). Clinical outcomes between DVT-only and AF
cohorts are shown in Supplemental table 6.
The incidence of arterial thromboembolic event was lower in the DVT-only
cohort than that in the AF cohort (SHR, 0.62; 95% CI, 0.59–0.65)
(Figure 3A). The risks of ischemic stroke (SHR, 0.45; 95% CI,
0.43–0.48) (Figure 3B) and MI (SHR, 0.76; 95% CI, 0.67–0.86) were
lower, while the risk of ECATE was higher, in the DVT-only cohort (SHR,
1.31; 95% CI, 1.20–1.43) (Figure 3C). All-cause mortality rates were
higher in the DVT-only cohort (HR, 1.14; 95% CI, 1.11–1.17), while the
rate of CV death was lower (HR, 0.89; 95% CI, 0.85–0.92) (Figure 3D
and Figure 3E).